Impact of RWE on HTA Decision-making

Download “Impact of RWE on HTA Decision-making”

• Explore the potential role of RWE in oncology health technology assessments, where unmet needs and obstacles to developing clinical evidence are particularly high.HTA at the EU level

• Discover promising signs of growing RWE acceptance and impact, with an examination of key drivers and barriers of historic RWE acceptance, building on work presented at ISPOR Europe 2022.

• Consider the value of RWE in overcoming payer uncertainties and the role it could play in allowing for faster patient access, with a discussion of initiatives and strategies to standardize and optimize the way RWE is evaluated across Europe.